Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Strongbridge Biopharma plc, Medical Devices Deals, 2011 to YTD 2017 10
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Strongbridge Biopharma Acquires US rights to Keveyis from Taro Pharma 13
Strongbridge Biopharma Acquires Somatoprim from Aspireo Pharma 15
Licensing Agreements 16
Cortendo Enters into Licensing Agreement with Antisense Therapeutics 16
Equity Offering 18
Strongbridge Biopharma Raises USD25 Million in Public Offering of Shares 18
Strongbridge Biopharma Raises USD3 Million in Private Placement of Shares 20
Strongbridge Biopharma to Raise USD40 Million in Public Offering of Shares 21
Strongbridge Biopharma Plans to Raise Funds through Private Placement of Shares 22
Strongbridge Biopharma Raises USD35 Million in Private Placement of Shares and Warrants 23
Strongbridge Biopharma Raises USD25 Million in IPO 25
Cortendo Raises USD33.2 Million in Private Placement of Shares 27
Cortendo to Raise USD33.2 Million in Private Placement of Shares 28
Strongbridge Biopharma Raises USD26.4 Million in Private Placement of Shares 30
Cortendo Raises USD37.5 Million in Private Placement of Shares 31
Cortendo Raises USD11 Million in Private Placement of Shares 33
Cortendo Raises USD12.6 Million in Private Placement of Shares 34
Cortendo Raises USD2.1 Million in Private Placement of Shares 35
Cortendo Raises USD0.7 Million in Private Placement of Shares 36
Cortendo Raises USD3.1 Million in Private Placement of Shares 37
Strongbridge Biopharma plc – Key Competitors 38
Strongbridge Biopharma plc – Key Employees 39
Strongbridge Biopharma plc – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Financial Announcements 41
Nov 14, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Third Quarter 2017 Financial Results 41
Aug 07, 2017: Strongbridge Biopharma Provides Updates on KEVEYIS Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results 44
May 16, 2017: Strongbridge Biopharma Provides Corporate Update and Reports First Quarter 2017 Financial Results 47
Mar 27, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Full-Year 2016 Financial Results 49
Dec 23, 2016: Strongbridge Biopharma Provides Corporate and Financial Update 51
May 17, 2016: Strongbridge Biopharma Reports First Quarter 2016 Financial Results 54
Mar 24, 2016: Strongbridge Biopharma Reports Full-Year 2015 Financial Results 55
Corporate Communications 56
Oct 03, 2016: Strongbridge Biopharma Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors 56
Product News 57
05/31/2016: Strongbridge Biopharma Announces Presentation of COR-003 Data at the European Congress of Endocrinology 57
Clinical Trials 58
May 31, 2016: Strongbridge Biopharma plc Announces Presentation of COR-005 Data at the European Congress of Endocrinology 58
Apr 04, 2016: Strongbridge Biopharma Announces Presentation of COR-003 Data at the Endocrine Society’s 2016 Annual Conference 59
Other Significant Developments 60
Sep 25, 2017: Strongbridge Biopharma Launches the Uncovering Periodic Paralysis Genetic Testing Program 60
Mar 07, 2016: Strongbridge Biopharma Provides Update on Corporate Progress 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Key Facts 2
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Strongbridge Biopharma plc, Deals By Therapy Area, 2011 to YTD 2017 9
Strongbridge Biopharma plc, Medical Devices Deals, 2011 to YTD 2017 10
Strongbridge Biopharma plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Strongbridge Biopharma Acquires US rights to Keveyis from Taro Pharma 13
Strongbridge Biopharma Acquires Somatoprim from Aspireo Pharma 15
Cortendo Enters into Licensing Agreement with Antisense Therapeutics 16
Strongbridge Biopharma Raises USD25 Million in Public Offering of Shares 18
Strongbridge Biopharma Raises USD3 Million in Private Placement of Shares 20
Strongbridge Biopharma to Raise USD40 Million in Public Offering of Shares 21
Strongbridge Biopharma Plans to Raise Funds through Private Placement of Shares 22
Strongbridge Biopharma Raises USD35 Million in Private Placement of Shares and Warrants 23
Strongbridge Biopharma Raises USD25 Million in IPO 25
Cortendo Raises USD33.2 Million in Private Placement of Shares 27
Cortendo to Raise USD33.2 Million in Private Placement of Shares 28
Strongbridge Biopharma Raises USD26.4 Million in Private Placement of Shares 30
Cortendo Raises USD37.5 Million in Private Placement of Shares 31
Cortendo Raises USD11 Million in Private Placement of Shares 33
Cortendo Raises USD12.6 Million in Private Placement of Shares 34
Cortendo Raises USD2.1 Million in Private Placement of Shares 35
Cortendo Raises USD0.7 Million in Private Placement of Shares 36
Cortendo Raises USD3.1 Million in Private Placement of Shares 37
Strongbridge Biopharma plc, Key Competitors 38
Strongbridge Biopharma plc, Key Employees 39
Strongbridge Biopharma plc, Subsidiaries 40